Common questions about Monural (FAQ)
Q: What are the most common reasons someone is prescribed Monural?
Official product information states that Monural (fosfomycin) is indicated for treating uncomplicated urinary tract infections (acute cystitis) in women. The medicine also has an approved indication for prophylaxis (prevention of infection) during specific urological procedures like a transrectal prostate biopsy in adult men.
Q: How quickly does Monural usually start working?
Patient information from regulatory sources indicates that symptoms should typically begin to show improvement within two to three days after taking the single dose. If symptoms are not improved in that time frame, official guidance suggests that a healthcare provider be contacted.
Q: Can Monural be used for infections outside of the urinary tract?
The approved indications for the oral granules are limited to the treatment of uncomplicated urinary tract infections and prophylaxis for a specific procedure. The approved scope does not include treating infections that are located outside of the urinary tract.
Q: Does taking Monural require any follow-up blood tests?
The official label suggests that urine specimens should be obtained for culture and susceptibility testing both before and after therapy is completed. Routine blood tests for monitoring the patient are generally not specified in the product's prescribing information.
Q: Is there any research evidence supporting the use of Monural for recurrent UTIs?
The primary approved use for this oral single-dose product is for uncomplicated acute cystitis. Official regulatory documentation primarily addresses its use for uncomplicated acute cystitis, and evidence for recurrent infections may be more limited.
Q: Does Monural contain any common allergens like lactose or gluten?
The inactive ingredients listed in the U.S. label include mandarin and orange flavorings, saccharin, and sucrose. The product is not recommended for people with a condition called hereditary fructose intolerance due to the excipients (non-active ingredients), but official labels do not explicitly mention lactose or gluten.
Q: Can Monural be used if I have a history of liver problems?
The product information notes that fosfomycin is primarily eliminated by the kidneys. Clinical experience and studies have not reported evidence of hepatic dysfunction being a general exclusion criterion. Eligibility is determined by a healthcare provider.
Q: Are there specific clinical guidelines that recommend Monural?
Official regulatory documents, such as the Summary of Product Characteristics, advise that the medicine should be used with consideration for official guidance on the appropriate use of antibacterial agents. This refers to nationally or internationally recognized clinical recommendations.
Q: Are there alternatives if Monural doesn't resolve the infection?
If the symptoms do not improve within two to three days after the dose, official guidance suggests the patient contact their healthcare provider. The selection of any alternative antibiotic treatment is decided by the prescriber.
Q: How long do the effects of Monural last in the body?
Fosfomycin is primarily eliminated by the kidneys, and the active concentration in the urine is the key factor. Studies show that effective urinary concentrations, necessary for clearing bacteria, are generally maintained for at least 24 hours after the single dose is taken.
Q: Are there any specific foods or drinks that should be avoided when taking Monural?
Official prescribing information indicates that taking Monural with food is not recommended. This is because concomitant food intake, particularly a high-fat meal, can reduce the rate and extent to which the drug is absorbed, although it doesn't change the total amount eventually excreted in the urine.
Q: Does Monural cause drowsiness or affect driving ability?
Common side effects listed for this medicine include headache and dizziness. The Summary of Product Characteristics advises that these types of effects may influence a patient’s ability to drive or operate machinery. A patient's ability to drive may be influenced by these effects.
Q: What kind of bacteria does Monural typically target?
The official product information specifies that Monural is indicated for infections caused by susceptible strains of two common types of bacteria: Escherichia coli (E. coli) and Enterococcus faecalis. These bacteria are often the cause of uncomplicated urinary tract infections.
Q: Does Monural have a high potential for drug interactions?
Regulatory labeling lists only a limited number of medicines that cause clinically significant interactions. The most noted interaction is with agents that increase gastrointestinal movement, like metoclopramide, which is not recommended as it lowers the concentration of fosfomycin in the body.
Q: What if I experience unusual symptoms after taking Monural?
In the event of severe, persistent diarrhea, fever, bloody stools, or signs of an allergic reaction (such as swelling of the face or difficulty breathing), official guidance suggests immediate contact with a healthcare provider. These are noted as rare but potentially serious adverse events.
Q: Does Monural affect the body's natural gut flora?
Yes, as with many antibiotics, there is a risk that Monural can disrupt the natural balance of bacteria in the gut. This disruption is the reason the product information includes a warning about the risk of severe antibiotic-associated colitis, caused by Clostridioides difficile.
Q: Has Monural been approved by the FDA or similar bodies for use in the US?
Yes, Monural (fosfomycin tromethamine) has received approval from the U.S. Food and Drug Administration (FDA) for its specific indicated uses. Regulatory documents from other bodies like the European Medicines Agency (EMA) also govern its use internationally.
Q: What research is available on Monural for use in older adults?
Clinical studies did not contain enough participants over the age of 65 to make a definitive statement on whether they respond differently than younger patients. However, existing clinical experience has generally not identified differences in response, provided the patient’s kidney function is monitored.
Q: Can men use Monural for UTIs, or is it mostly for women?
Regulatory documents describe Monural as indicated for uncomplicated UTIs in women and female adolescents. However, it is also approved for a prophylactic (preventative) role in adult men who are undergoing a transrectal prostate biopsy procedure.
Q: Does Monural treat viral infections?
No. Official product information confirms that Monural is an antibiotic, and its mechanism of action is designed to target and kill susceptible bacteria. It is not effective against any kind of viral infection.
Q: What is the role of Monural in preventative care for UTIs?
The official approved role for Monural in preventative care is limited to its use as antibiotic prophylaxis for adult men undergoing a specific surgical procedure, a transrectal prostate biopsy. Its role in general, non-procedural prevention of UTIs is not part of the standard approved indication.
